Those who qualify may receive*:
The ABTECT Study will last for up to 16 weeks. You will be randomly assigned to receive 1 dose of the investigational medication, or a placebo. The placebo looks just like the investigational medication but contains no active ingredients.
Approximately 612 people, 18 years of age or older will take part in the study.
If you are eligible to take part, you will need to visit the study center at least 6 times. There will also be times when you will need to contact the study team by telephone.
Our team will contact you to verify your eligiblity and answer any questions you may have.